We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Friday 13th September 2024 13:00 - 14:00 (BST)
Our panel of industry leaders came together for a deep dive into the current and future landscape of Generics, Branded Generics, and Biosimilars, exploring the pressing issues, opportunities, and emerging trends in the sector.
With a focus on the evolving political environment, we examined how the recent government changes could impact policy, procurement, and patient outcomes. The discussion covered the importance of continued engagement between the government and the off-patent sector, emphasising the vital role of generics and biosimilars in ensuring affordable healthcare.
Our speakers also addressed the challenges of maintaining a sustainable supply chain, highlighting the pressures caused by low-cost reimbursement models. The potential for biosimilars to increase patient access and reduce costs was another key topic, along with the future role of branded generics in hospital care.
13th Sep 2024 13:00 – 14:00 (BST)
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now